Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;51(5):367-9.
doi: 10.1310/hpj5105-367.

Pyridostigmine: Postpoliomyelitis Syndrome

Joyce A Generali, Dennis J Cada

Pyridostigmine: Postpoliomyelitis Syndrome

Joyce A Generali et al. Hosp Pharm. 2016 May.

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Farbu E, Gilhus NE, Barnes MP et al. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol. 2006;13(8):795–801. - PubMed
    1. Boyer FC, Tiffreau V, Rapin A et al. Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy. Ann Phys Rehabil Med. 2010;53(1):34–41. - PubMed
    1. Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. Treatment for postpolio syndrome. Cochrane Database Syst Rev. 2015;5:CD007818. - PMC - PubMed
    1. Trojan DA, Collet JP, Shapiro S et al. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology. 1999;53(6):1225–1233. - PubMed
    1. Horsemans HLD, Nollet F, Beelen A et al. Pyridostigmine in postpolio syndrome: No decline in fatigue and limited functional improvement. J Neurol Neurosurg Psychiatry. 2003;74:1655–1661. - PMC - PubMed

LinkOut - more resources